|Articles|March 1, 2006

Pharmacy Times

  • Volume 0
  • 0

HDL May Protect Kidneys in Patients with Diabetes

Researchers from NorthwesternUniversity (Chicago, Ill)report that higher levels ofhigh-density lipoprotein (HDL),the "good" cholesterol, areassociated with a lower risk ofprotein in the urine (albuminuria),a sign of kidney disease,in patients with type 1 diabetes.The findings were publishedin the January edition ofDiabetes Care.

The cholesterol profiles of107 patients who had type 1diabetes for at least 20 yearswere analyzed. Forty-twopatients had albuminuria, and65 did not. Total cholesterol,low-density lipoprotein, andtriglyceride levels were all similarin both sets of patients. HDLlevels, however, were significantlylower in patients withalbuminuria, compared withthose without the condition.When the age, sex, duration,and degree of patients' diabeteswere taken into account,the odds of having albuminuriawere cut in half for every 21-mg/dL increase in HDL.

Whether the higher HDL isprotective of the patients' kidneys,or whether it reflectssome other mechanism, isunknown, researchers said.They agree that this is a "verypreliminary report that needsconfirmation in larger numbersof patients."

Articles in this issue

almost 20 years ago

Suing a Lawyer for Malpractice?

almost 20 years ago

Pharmacists—Cops or Not? (Part 1)

almost 20 years ago

Can You Read These Rxs?

almost 20 years ago

Compounding Hotline

almost 20 years ago

Obesity May Lead to Kidney Failure

almost 20 years ago

Midlife Obesity May Cause Heart Disease

almost 20 years ago

The Evolution of Imprint Identification

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME